Physician profile
Jay Fu
NPI 1235226192
$1,109.36
in general payments reported to CMS, 2019-2025
16 companies · $18.57 in 2025
The $18.57 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $298 · 2021: $346 · 2023: $14.63 · 2025: $18.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $186.65 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $181.60 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $136.21 | 2020-2021 | |
| Opko Pharmaceuticals, LLC | $125.44 | 2019-2020 | |
| Daiichi Sankyo INC. | $115.67 | 2019-2021 | |
| Amgen INC. | $88.23 | 2019-2021 | |
| Aurinia Pharma U.S., INC. | $57.56 | 2021 | |
| Horizon Therapeutics Plc | $48.73 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $35.10 | 2019-2021 | |
| Nuwellis, INC. | $25.15 | 2021 | |
| Mallinckrodt Enterprises LLC | $20.56 | 2019 | |
| Vifor Pharma, INC. | $20.00 | 2019 | |
| Ani Pharmaceuticals, INC. | $18.57 | 2025 | Purified Cortrophin Gel |
| Alnylam Pharmaceuticals INC. | $17.76 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.50 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $14.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.